Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma

被引:55
作者
Ebelt, Kathleen [1 ,2 ]
Babaryka, Gregor [3 ]
Figel, Ainhoa M. [1 ]
Pohla, Heike [1 ,4 ]
Buchner, Alexander [5 ]
Stief, Christian G. [5 ]
Eisenmenger, Wolfgang [6 ]
Kirchner, Thomas [3 ]
Schendel, Dolores J. [1 ,2 ]
Noessner, Elfriede [1 ]
机构
[1] GSF Natl Res Ctr Environm & Hlth, Inst Mol Immunol, D-81377 Munich, Germany
[2] GSF Natl Res Ctr Environm & Hlth, Clin Cooperat Grp Immune Monitoring, D-81377 Munich, Germany
[3] Univ Munich, Inst Pathol, D-8000 Munich, Germany
[4] Univ Munich, Lab Tumor Immunol, D-8000 Munich, Germany
[5] Clin Ludwig Maximilians Univ, Univ Hosp Grosshadern, Dept Urol, Munich, Germany
[6] Univ Munich, Inst Legal Med, D-8000 Munich, Germany
关键词
tumor-infiltrating lymphocytes; IFN-gamma; perforin; T-cell-receptor repertoire;
D O I
10.1002/pros.20661
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND. Prostate cancer is the most common cancer of men in the Western world. Despite the over-expression of tumor-associated antigens, like PSA or PSMA, immune activation is inefficient. The goal of this investigation was to assess in situ characteristics of prostate cancer-infiltrating lymphocytes and to determine their activation status and effector function. METHODS. We compared 17 carcinoma containing tissues, four benign prostatic hyperplasia tissues and eight healthy prostate tissues regarding lymphocyte subset composition, locoregional distribution, and functional status using immunohistological staining of cryopreserved tissues. For determination of lymphocyte subsets, serial sections were stained with CD3, CD4, and CD8 antibodies. Activation status and effector function were studied using CD69, interferon-gamma (IFN gamma), perforin, and CD3 zeta chain antibodies. T-cell-receptor repertoire (TCR) analysis was made to determine the complexity of infiltrating lymphocytes. RESULTS. CD3(+), CD4(+), and CD69(+) T lymphocytes were prominent in tissues derived from patients with prostate carcinoma. CD8(+) lymphocytes were significantly less than CD4+ lymphocytes. IFN gamma and perforin were downregulated on infiltrating lymphocytes compared to cells of healthy prostate tissue. Very few lymphocytes were detected within cancerous lesions whereas surrounding tissues showed extensive lymphocyte cluster formation. The TCR repertoire of infiltrating lymphocytes was broad and similar to that of healthy prostate tissue, giving no evidence for specific lymphocyte recruitment. CONCLUSIONS. In the prostate cancer microenvironment, CD4(+) T lymphocytes dominated while CD8+ T cells were sparse. The lymphocytes exhibited signs of disturbed effector function. Consequently, the immune response against autologous tumor cells is likely to be inefficient in controlling tumor growth.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 42 条
[1]
Arden Bernhard, 1995, Immunogenetics, V42, P455
[2]
BALCH CM, 1990, ARCH SURG-CHICAGO, V125, P200
[3]
The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis [J].
Blankenstein, T ;
Qin, ZH .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (02) :148-154
[4]
INCIDENTAL LYMPHOCYTIC PROSTATITIS - SELECTIVE INVOLVEMENT WITH NONMALIGNANT GLANDS [J].
BLUMENFELD, W ;
TUCCI, S ;
NARAYAN, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (10) :975-981
[5]
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers [J].
Bronte, V ;
Kasic, T ;
Gri, G ;
Gallana, K ;
Borsellino, G ;
Marigo, I ;
Battistini, L ;
Iafrate, M ;
Prayer-Galetti, T ;
Pagano, F ;
Viola, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1257-1268
[6]
Eerola AK, 2000, CLIN CANCER RES, V6, P1875
[7]
Elsässer-Beile U, 2000, PROSTATE, V45, P1, DOI 10.1002/1097-0045(20000915)45:1<1::AID-PROS1>3.0.CO
[8]
2-V
[9]
Enhanced expression of IFN-γ mRNA in CD4+ or CD8+ tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer [J].
Elsässer-Beile, U ;
Rindsfüser, M ;
Grussenmeyer, T ;
Schultze-Seemann, W ;
Wetterauer, U .
BRITISH JOURNAL OF CANCER, 2000, 83 (05) :637-641
[10]
Enhanced antitumor immunity in mice deficient in CD69 [J].
Esplugues, E ;
Sancho, D ;
Vega-Ramos, J ;
Martínez-A, C ;
Syrbe, U ;
Hamann, A ;
Engel, P ;
Sánchez-Madrid, F ;
Lauzurica, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1093-1106